Migraine has greater impact on person's quality of life and also contributes a financial burden on health care system. Assessing quality of life of the patient has become an important tool that helps in the management of migraine. Educational programs are used to provide information and teaching the skills that are difficult to understand by patients. Migraine education programs by the Clinical Pharmacist will have a positive impact on person living with migraine understanding of the disease that results in satisfaction of the patient and can also improve migraineur physician consultation rates and overall care. The study revealed that mostly prescribed monotherapy agent is NSAID and single pill combination therapy is Antiemetic and NSAID. Monotherapy is mostly preferred than combination therapy. There was a significant improvement in the Health-related Quality of Life in the both scales, MSQ and SF 36. The patient education along with appropriate treatment helped the Migraine patients in the improvement of their Health-related Quality of life and thus decreased the Migraine related burden on the individual.